17 insiders reported 27 Form 4 transactions for Kyverna Therapeutics, Inc. (KYTX) over the past 18 months (most recent 2026-05-29). Recent activity: SEIDENBERG BETH C (Director) Buy 5,093 shares, CLARK IAN T (Director) Buy 5,093 shares, Cohen Fred E (Director) Buy 5,093 shares, Shaw Christi (Executive Chairperson) Sell 4,194 shares, Aktar Mert (Director) Buy 5,093 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-29 | SEIDENBERG BETH C | Director | Buy | 5,093 | $0 |
| 2026-05-29 | CLARK IAN T | Director | Buy | 5,093 | $0 |
| 2026-05-29 | Cohen Fred E | Director | Buy | 5,093 | $0 |
| 2026-05-29 | Shaw Christi | Executive Chairperson | Sell | 4,194 | $36,026 |
| 2026-05-29 | Aktar Mert | Director | Buy | 5,093 | $0 |
| 2026-03-17 | GRASSO MARC | Chief Financial Officer | Buy | 10,000 | $0 |
| 2026-03-17 | Biddle Warner Weston | Chief Executive Officer | Buy | 58,000 | $0 |
| 2026-03-17 | GEHCHAN NAJI | See Remarks | Buy | 18,000 | $0 |
| 2026-03-04 | Miller Andrew Craig | Director | Buy | 11,006 | $0 |
| 2026-02-26 | Emany Sravan Kumar | Director | Buy | 11,006 | $0 |
| 2026-01-14 | Shaw Christi | Executive Chairperson | Buy | 30,000 | $0 |
| 2026-01-14 | Shaw Christi | Executive Chairperson | Buy | 24,301 | $0 |
| 2025-12-22 | Westlake BioPartners Opportunity GP I, LLC | Insider | Buy | 133,333 | $999,998 |
| 2025-12-22 | Westlake BioPartners Opportunity Fund I, L.P. | Insider | Buy | 133,333 | $999,998 |
| 2025-12-22 | Westlake BioPartners GP I, LLC | Insider | Buy | 133,333 | $999,998 |
| 2025-12-22 | SEIDENBERG BETH C | Director | Buy | 133,333 | $999,998 |
| 2025-12-22 | Westlake BioPartners Fund I, L.P. | Insider | Buy | 133,333 | $999,998 |
| 2025-12-17 | Walker Karen Marie | Chief Technology Officer | Buy | 23,998 | $115,910 |
| 2025-12-17 | Walker Karen Marie | Chief Technology Officer | Sell | 23,998 | $292,776 |
| 2025-06-02 | Aktar Mert | Director | Buy | 16,634 | $0 |
| 2025-06-02 | Cohen Fred E | Director | Buy | 16,634 | $0 |
| 2025-06-02 | SPIEGELMAN DANIEL K | Director | Buy | 16,634 | $0 |
| 2025-06-02 | CLARK IAN T | Director | Buy | 16,634 | $0 |
| 2025-06-02 | SEIDENBERG BETH C | Director | Buy | 16,634 | $0 |
| 2025-06-02 | Shaw Christi | Director | Buy | 16,634 | $0 |
Source: SEC Form 4 filings · as of 2026-05-29